Loading company…
Rapid Micro Biosystems develops systems and tests for detecting microbial contamination.
Founded in 2006, Rapid Micro Biosystems develops microbial contamination detection products for pharmaceutical, biologics, vaccine, medical device and personal care manufacturing. Its offerings include the Growth Direct platform, consumables, services and applications for environmental monitoring, water and bioburden testing. The company raised USD 81 million in venture funding in March 2021 from Adage Capital Management, D1 Capital Partners, Longitude Capital, and T. Rowe Price.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in